A Case of Neisseria sicca Bacteremia Due to Eculizumab Therapy
Eculizumab is a monoclonal antibody indicated for the treatment of complement-mediated disorders. Despite its utility, eculizumab increases risk for infection with Neisseria species, owing to membrane attack complex inhibition. Although this naturally evokes thought of infection with N meningitidis,...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American College of Physicians
2023-06-01
|
| Col·lecció: | Annals of Internal Medicine: Clinical Cases |
| Accés en línia: | https://www.acpjournals.org/doi/10.7326/aimcc.2022.0934 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|